82.Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. - Interpretative strategies for lung function tests. Eur Respir J. 2005, 26: 948-968.

83.Hankinson JL, Odencratz JR, Fedan KB. - Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999, 159: 179 - 187.

84.Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. - Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002, 20: 1117 - 1122.

85.Stocks J, Quanjer PH. - Reference values for residual volume, functional residual capacity and total lung capacity. Eur Respir J. 1995, 8: 492 - 506.

86.McCarthy DS, Craig DB, Cherniak RM - Intraindividual variability in maximal expiratory flow-volume and closing volume in asymptomatic subjects. Am Rev Respir Dis. 1975, 112: 407-411.

87.Wise RA, Connett J, Kurnow K, et al. - Selection of spirometric measurements in a clinical trial, the Lung Health Study. Am J Respir Crit Care Med. 1995, 151: 675-681.

88.Wang ML, McCabe L, Petsonk EL, et al. - Weight gain and longitudinal changes in lung function in steel workers. Chest. 1997, 111: 1526-1532.

89.American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor): Recommendations for a standard technique. Am Rev Respir Dis 1987; 136:1299.

90.American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): Recommendations for a standard technique 1995 update. Am J Respir Crit Care Med 1995; 152:2185.

91.Morrison, NJ, Abboud, RT, Ramadan, F, et al. Comparison of DLCO and pressure-volume curves in detecting emphysema. Am Rev Respir Dis 1989; 139:1179.

92.Gould, GA, Redpath, AT, Ryan, M, et al. Lung CT density correlates with measurements of airflow limitation and diffusing capacity. Eur Respir J 1991; 4:141.

93.Stewart, RI. Carbon monoxide diffusing capacity in asthmatic patients with mild airflow limitation. Chest 1988; 94:332.

94.DoPico, GA, Wiley, AL Jr, Rao, P, Dickie, HA. Pulmonary reaction in upper mantle radiation therapy for Hodgkin's disease. Chest 1979; 75:688.

95.Luursema, PB, Star-Kroesen, MA, VanDer Mark, THW, et al. Bleomycin-induced changes in the carbon monoxide transfer factor of the lungs and its components. Am Rev Respir Dis 1983; 128:880.

96.Crawford, SW, Pepe, M, Lin, D, et al. Abnormalities of pulmonary function tests after marrow transplantation predict nonrelapse mortality. Am J Respir Crit Care Med 1995; 152:690.

97.Mitchell, DM, Fleming, J, Pinching, AJ, et al. Pulmonary function in human immunodeficiency virus infection. Am Rev Respir Dis 1992; 146:745.

98.Nieman, RB, Fleming, J, Coker, RJ, et al. Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS. Thorax 1993; 48:481.

99.Watters, LC, King, TE, Schwartz, MI, et al. A clinical, radiographic, and physiologic scoring system for the longitudinal assissment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 133:97.

100.Helmers, RA, Dayton, CS, Burmeister, LF, Hunninghake, GW. Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149:444.

101.Fernandez-Bonetti, P, Lupi-Herrera, E, Martinez-Guerra, ML, et al. Peripheral airways obstruction in idiopathic pulmonary artery hypertension. Chest 1983; 83:732.

102.Tashkin, DP, Clements, PJ, Wright, RS, et al. Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. Chest 1994; 105:489.

103.Hills, EA, Geary, M. Membrane diffusing capacity and pulmonary capillary volume in rheumatoid disease. Thorax 1980; 35:851.

104.American Medical Association. Guides to the Evaluation of Permanent Impairment, 2d ed, American Medical Association, Chicago, 1984, p. 86.

105.American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 1986; 133:1205.

106.Miller, A, Thornton, JC, Warshaw, R, et al. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Am Rev Respir Dis 1983; 127:270.

107.Rijcken, B, Schouten, JP, Xu, X, et al. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. Am J Respir Crit Care Med 1995; 151:1377.

108.Kitaichi, M, Nishimura, K, Itoh, H, Izumi, T. Pulmonary lymphangioleiomyomatosis: A report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 1995; 151:527.

109.Sansores, RH, Abboud, RT, Kennell, C, Haynes, N. The effect of menstruation on the pulmonary carbon monoxide diffusing capacity. Am J Respir Crit Care Med 1995; 152:381.

110.Sansores, RH, Pare, PD, Abboud, RT. Acute effect of cigarette smoking on the carbon monoxide diffusing capacity of the lung. Am Rev Respir Dis 1992; 146:951.

111.Sansores, RH, Pare, P, Abboud, RJ. Effect of smoking cessation on pulmonary carbon monoxide diffusing capacity and capillary blood volume. Am Rev Respir Dis 1992; 146:959.

112.Crapo, RO, Morris, AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981; 123:185.

113.Johnson, DC. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume. Respir Med 2000; 94:28.

114.Kanengiser, LC, Rapoport, DM, Epstein, H, Goldring, RM. Volume adjustment of mechanics and diffusion in interstitial lung disease. Chest 1989; 96:1036.

115.Kangalee, KM, Abboud, RT. Interlaboratory and intralaboratory variability in pulmonary function testing. A 13 year study using a normal biologic control. Chest 1992; 101:88.

116.Mushtaq, M, Hayton, R, Watts, T, et al. An audit of pulmonary function laboratories in the West Midlands. Respir Med 1995; 89:263.

117.Hathaway, EH, Tashkin, DP, Simmons, MS. Intraindividual variability in serial measurement of DLCO and alveolar volume over one year in eight healthy subjects using three independent measuring systems. Am Rev Respir Dis 1989; 140:1818.

118.European Respiratory Society. Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J 1993; 6(Suppl 16):41.

119.Mead J, Loring SH: Analysis of volume displacement and length changes of the diaphragm during breathing. J Appl Physiol 53:750-755, 1982.

120.Severinghaus JW, Stupfel M: Alveolar dead space as an index of distribution of blood flow in pulmonary capillaries. J Appl Physiol 10:335-348, 1957.

121.Mellemgaard K: The alveolar-arterial oxygen difference: size and components in normal man. Acta Physiol Scand 67:10-20, 1966.

122.West JB: Ventilation-perfusion inequality and overall gas exchange in computer models of the lung. Respir Physiol 7:88-110, 1969.

123.West JB: Causes of carbon dioxide retention in lung disease. N Engl J Med 284:1232-1236, 1971.

124.Lilienthal JL Jr, Riley RL, Premmel DD, et al: An experimental analysis in man of the oxygen pressure gradient from alveolar air to arterial blood during rest and exercise at sea level and at altitude. Am J Physiol 147:199-216, 1946.

125.Riley RL, Cournand A: Analysis of factors affecting partial pressures of oxygen and carbon dioxide in gas and blood of lungs: theory. J Appl Physiol 4:77-101, 1951.

126.Bryan AC, Bentivoglio LG, Beerel F, et al: Factors affecting regional distribution of ventilation and perfusion in the lung. J Appl Physiol 19:395-402, 1964.

127.Wagner HN Jr, Sabiston DC Jr, Iio M, et al: Regional pulmonary blood flow in man by radioisotope scanning. JAMA 187:601-603, 1964.